Please wait...

Learn

Finding accredited CPD

Medicinal Cannabis - PTSD – Treatment in clinical practice

Description

The "Medicinal Cannabis - PTSD: Treatment in Clinical Practice" course offers an in-depth understanding of PTSD and its treatment with medicinal cannabis. Led by experienced clinician Dr. John Teh, this program provides the tools and knowledge required to incorporate cannabinoid therapies into PTSD management effectively.

Unit 1 introduces PTSD, covering its symptoms, diagnostic criteria, and underlying neurobiology. Participants learn how traumatic events trigger physiological responses, including hypervigilance, avoidance, emotional dysregulation, and memory alterations. The unit establishes a foundation for understanding the role of the endocannabinoid system in PTSD and its potential therapeutic implications.

Unit 2 focuses on treatment approaches, comparing conventional options such as SSRIs, antipsychotics, and psychotherapy with medicinal cannabis therapies. The unit explains how cannabinoids like CBD and THC interact with the endocannabinoid system to reduce anxiety, regulate emotions, and facilitate fear extinction. Detailed dosing strategies for oral, sublingual, and inhaled cannabis are provided, emphasising personalised care.

Unit 3 explores the regulatory landscape for medicinal cannabis in PTSD treatment, particularly in Australia. It discusses the policies of the Department of Veterans Affairs (DVA) and offers guidance on securing funding for veterans with chronic pain or PTSD-related symptoms. Participants learn to navigate legal and bureaucratic processes to support their patients.

Unit 4 uses case studies to illustrate the practical application of cannabinoid therapies. Two detailed cases highlight tailored treatment plans for veterans with PTSD, demonstrating how individualised dosing and cannabinoid selection can address symptoms like anxiety, hypervigilance, insomnia, and pain. These real-world examples underscore the importance of titrating treatments to patient needs while considering co-morbidities and prior cannabis use.

This course equips healthcare professionals with the knowledge to integrate medicinal cannabis into PTSD treatment safely and effectively, ensuring improved patient outcomes and advancing clinical practice in this evolving field.


Learning Outcomes

  1. Assess the use of medicinal cannabis for PTSD, including dosage and treatment in clinical practice.

Details

Cost: $195

Suitable for: All degree qualified medical practitioners.

Study mode: 100% online

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

Upon completion, your CPD activity record may take up to 4 weeks to be reflected on your CPD Home Dashboard. 

CPD Activity Details
Provider
Domain
Educational Activities
Type
General Learning
Activity
Course / module
CPD Hours
10h : 0m
Topic
General Practice and Primary Care
Audience
Medical practitioners
Applicable CAPE Aspects
_
Effective Year

You have to log in to see the content of this module.


Provided by


Accredited by

*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)